Skin Analytics
AI-driven skin cancer assessment tool designed to support dermatology triage.
What they do
The company develops an artificial intelligence tool, DERM, that analyzes macro images of skin lesions to detect melanoma and other skin cancers. Healthcare organizations use the tool in primary care hubs to optimize hospital referral pathways.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Dermatology AI diagnostics
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2012
- Total funding
- $10M raised
Notable investors: Hoxton Ventures, Nesta, Mustard Seed.